DI/cle, a Measure Consisting of Insulin Sensitivity, Secretion, and Clearance, Captures Diabetic States

Context Insulin clearance is implicated in regulation of glucose homeostasis independently of insulin sensitivity and insulin secretion. Objective To understand the relation between blood glucose and insulin sensitivity, secretion, and clearance. Methods We performed a hyperglycemic clamp, a hyperinsulinemic-euglycemic clamp, and an oral glucose tolerance test (OGTT) in 47, 16, and 49 subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and type 2 diabetes mellitus (T2DM), respectively. Mathematical analyses were retrospectively performed on this dataset. Results The disposition index (DI), defined as the product of insulin sensitivity and secretion, showed a weak correlation with blood glucose levels, especially in IGT (r = 0.04; 95% CI, −0.63– 0.44). However, an equation relating DI, insulin clearance, and blood glucose levels was well conserved regardless of the extent of glucose intolerance. As a measure of the effect of insulin, we developed an index, designated “DI/cle,” that is based on this equation and corresponds to DI divided by the square of insulin clearance. DI/cle was not impaired in IGT compared with NGT, possibly as a result of a decrease in insulin clearance in response to a reduction in DI, whereas it was impaired in T2DM relative to IGT. Moreover, DI/cle estimated from a hyperinsulinemic-euglycemic clamp, OGTT, or a fasting blood test were significantly correlated with that estimated from two clamp tests (r = 0.52; 95% CI, 0.37– 0.64, r = 0.43; 95% CI, 0.24– 0.58, and r = 0.54; 95% CI, 0.38– 0.68, respectively). Conclusions DI/cle can serve as a new indicator for the trajectory of changes in glucose tolerance.

[1]  K. Kajiwara,et al.  Potential Identification of Type 2 Diabetes with Elevated Insulin Clearance , 2022, NEJM Evidence.

[2]  E. Ferrannini,et al.  New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms , 2021, Diabetes Care.

[3]  C. Cobelli,et al.  Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials , 2021, Journal of diabetes science and technology.

[4]  R. Bergman Origins and History of the Minimal Model of Glucose Regulation , 2021, Frontiers in Endocrinology.

[5]  A. Tura,et al.  Insulin resistance in congenital adrenal hyperplasia is compensated for by reduced insulin clearance. , 2021, The Journal of clinical endocrinology and metabolism.

[6]  Roberto Bizzotto,et al.  Mathematical Modeling for the Physiological and Clinical Investigation of Glucose Homeostasis and Diabetes , 2020, Frontiers in Physiology.

[7]  R. DeFronzo,et al.  Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance , 2020, Diabetes.

[8]  R. Bergman,et al.  The Measurement of Insulin Clearance , 2020, Diabetes Care.

[9]  A. De Gaetano,et al.  A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program , 2019, PloS one.

[10]  S. Caprio,et al.  Lower Insulin Clearance Parallels a Reduced Insulin Sensitivity in Obese Youths and Is Associated With a Decline in β-Cell Function Over Time , 2019, Diabetes.

[11]  A. Sherman,et al.  Type 2 Diabetes: One Disease, Many Pathways , 2019, bioRxiv.

[12]  S. Caprio,et al.  Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis. , 2018, The Lancet. Child & adolescent health.

[13]  Shinya Kuroda,et al.  Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects , 2018, npj Systems Biology and Applications.

[14]  Shinya Kuroda,et al.  Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects , 2018, npj Systems Biology and Applications.

[15]  G. Reaven,et al.  Insulin clearance: an underappreciated modulator of plasma insulin concentration , 2016, Journal of Investigative Medicine.

[16]  Hiroyuki Kubota,et al.  Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans , 2015, PloS one.

[17]  A. Basu,et al.  The Forgotten Role of Glucose Effectiveness in the Regulation of Glucose Tolerance , 2015, Current Diabetes Reports.

[18]  R. DeFronzo,et al.  The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone. , 2014, The Journal of clinical endocrinology and metabolism.

[19]  S. Seino,et al.  Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes. , 2013, Metabolism: clinical and experimental.

[20]  Claudio Cobelli,et al.  The disposition index: from individual to population approach. , 2012, American journal of physiology. Endocrinology and metabolism.

[21]  Sara Taskinen,et al.  smatr 3– an R package for estimation and inference about allometric lines , 2012 .

[22]  J. Rotter,et al.  Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. , 2011, American journal of physiology. Endocrinology and metabolism.

[23]  Greg Gibson,et al.  Decanalization and the origin of complex disease , 2009, Nature Reviews Genetics.

[24]  Claudio Cobelli,et al.  Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. , 2007, American journal of physiology. Endocrinology and metabolism.

[25]  R. Bergman,et al.  Beta-cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model. , 2007, American journal of physiology. Endocrinology and metabolism.

[26]  R. Bergman,et al.  Longitudinal Compensation for Fat-induced Insulin Resistance Includes Reduced Insulin Clearance and Enhanced ␤-cell Response Research Design and Methods , 2022 .

[27]  R. Miura,et al.  A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to Diabetes , 2000 .

[28]  Ovide Arino,et al.  Mathematical modelling of the intravenous glucose tolerance test , 2000, Journal of mathematical biology.

[29]  K. Polonsky,et al.  Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. , 1997, The Journal of clinical endocrinology and metabolism.

[30]  R. Bergman,et al.  Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. , 1992, The American journal of physiology.

[31]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[32]  R. Bergman,et al.  Relationship of insulin clearance and secretion to insulin sensitivity in non‐diabetic Mexican Americans , 1992, European journal of clinical investigation.

[33]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[34]  SoJung Lee,et al.  Measuring b-Cell Function Relative to Insulin Sensitivity in Youth Does the hyperglycemic clamp suffice? , 2012 .

[35]  Michael Stumvoll,et al.  Glucose allostasis. , 2003, Diabetes.

[36]  G. Pacini,et al.  Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. , 1997, The American journal of physiology.